Date: June 21 - 24, 2023
Time: 9-17:00 CEST every day
Format: Poster presentation: Phase 2a study of CM-101, a CCL24 neutralizing antibody, in patients with nonalcoholic steatohepatitis: A proof-of-concept study
Presenter: Professor Rifaat Safadi, Professor in Medicine, Gastroenterology and Hepatology, Faculty of Medicine, Hadassah University Hospital, Jerusalem, Israel and visiting Scholar, Division of Liver Diseases, Mount Sinai School of Medicine, New York City, USA
Session: Poster-Late-Breaker, LBP-28
Information: https://congress-easl.com/